Lanean...
A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio
BACKGROUND: The prognosis of patients with stage I non-small cell lung cancer (NSCLC) is often uncertain. This study aims to investigate a new prognostic tool to classify stage I NSCLC patients more accurately. METHODS: CD68 and CD163 macrophages were quantified by immunohistochemical analyses of th...
Gorde:
| Argitaratua izan da: | Ann Transl Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7210133/ https://ncbi.nlm.nih.gov/pubmed/32395514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.113 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|